Human multipotent mesenchymal stromal cells from fetal lung expressing pluripotent markers and differentiating into cell types of three germ layers

Cell Transplantation

Volumn 18, Issue 10-11, 2009, Pages 1093-1109

  Cuiling, Zheng ^a   Shaoguang, Yang ^a   Zhenxing, Guo ^a,b   Wenbin, Liao ^a   Lei, Zhang ^a   Renchi, Yang ^a   Zhong, Chao Han ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

^b FIRST HOSPITAL OF TSINGHUA UNIVERSITY   (China)

Author keywords

Differentiation capacity; Fetal lung; Multipotent mesenchymal stromal cells; Pluripotent markers

Indexed keywords

AGGRECAN; BETA ACTIN; BIOLOGICAL MARKER; COLLAGEN TYPE 2; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; OSTEOCALCIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; PROTEIN TRA 1 60; STAGE SPECIFIC EMBRYO ANTIGEN 4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG;

ADIPOGENESIS; ANIMAL EXPERIMENT; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL EXPANSION; CELL GROWTH; CELL LINEAGE; CELL STRUCTURE; CELL TRANSPLANTATION; CELL TYPE; CHONDROGENESIS; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ECTODERM; ENDODERM; FEMALE; FETUS; FETUS LUNG; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IN VITRO STUDY; KARYOTYPE; MESODERM; MOUSE; MULTIPOTENT MESENCHYMAL STROMAL CELL; MULTIPOTENT STEM CELL; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TELOMERE; TISSUE INJURY; TISSUE REGENERATION;

BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL LINEAGE; ECTODERM; ENDODERM; FETUS; HUMANS; IMMUNOPHENOTYPING; KARYOTYPING; LUNG; MESENCHYMAL STEM CELLS; MESODERM; MULTIPOTENT STEM CELLS; TELOMERE;

EID: 75149198767     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368909X12483162197042     Document Type: Article

References (49)

1. Abdallah, B. M.; Haack-Sorensen, M.; Burns, J. S.; Elsnab, B.; Jakob, F.; Hokland, P.; Kassem, M. Maintenance of differentiation potential of human bone marrow mesenchymal stem cells immortalized by human telomerase reverse transcriptase gene despite [corrected] extensive proliferation. Biochem. Biophys. Res. Commun. 326:527-538; 2005.
2. Abdallah, B. M.; Kassem, M. The use of mesenchymal (skeletal) stem cells for treatment of degenerative diseases: Current status and future perspectives. J. Cell. Physiol. 218:9-12; 2009.
3. Arthur, A.; Zannettino, A.; Gronthos, S. The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repair. J. Cell. Physiol. 218:237-245; 2009.
4. Banfi, A.; Muraglia, A.; Dozin, B.; Mastrogiacomo, M.; Cancedda, R.; Quarto, R. Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stroma cells: Implication for their use in cell therapy. Exp. Hematol. 28:707-715; 2000.
5. Battula, V. L.; Bareiss, P. M.; Treml, S.; Conrad, S.; Albert, I.; Hojak, S.; Abele, H.; Schewe, B.; Just, L.; Skutella, T.; Bühring, H. J. Human placenta and bone marrow derived MSC cultured in serum-free, b-FGF-containing medium express cell surface frizzled-9 and SSEA-4 and give rise to multilineage differentiation. Differentiation 75:279-291; 2007.
6. Beltrami, A. P.; Cesselli, D.; Bergamin, N.; Marcon, P.; Rigo, S.; Puppato, E.; D'Aurizio, F.; Verardo, R.; Piazza, S.; Pignatelli, A.; Poz, A.; Baccarani, U.; Damiani, D.; Fanin, R.; Mariuzzi, L.; Finato, N.; Masolini, P.; Burelli, S.; Belluzzi, O.; Schneider, C.; Beltrami, C. A. Multipotent cells can be generated in vitro from several adult human organs (heart, liver, and bone marrow). Blood 110: 3438-3446; 2007.
7. Bieback, K.; Kern, S.; Klüter, H.; Eichler, H. Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells 22:625-634; 2004.
8. Bilic, G.; Zeisberger, S. M.; Mallik, A. S.; Zimmermann, R.; Zisch, A. H. Comparative characterization of cultured human termiamnion epithelial and mesenchymal stromal cells for application in cell therapy. Cell Transplant. 17:955-968; 2008.
9. Cai, X.; Lin, Y.; Ou, G.; Luo, E.; Man, Y.; Yuan, Q.; Gong, P. Ectopic osteogenesis and chondrogenesis of bone marrow stromal stem cells in alginate system. Cell Biol. Int. 31:776-783; 2007.
10. Campagnoli, C.; Roberts, I. A.; Kumar, S.; Bennett, P. R.; Bellantuono, I.; Fisk, N. M. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 98:2396-2402; 2001.
11. + perivascular cells and fibroblasts. Exp. Hematol. 36:642-654; 2008.
12. De Coppi, P.; Bartsch, Jr., G.; Siddiqui, M. M.; Xu, T.; Santos, C. C.; Perin, L.; Mostoslavsky, G.; Serre, A. C.; Snyder, E. Y.; Yoo, J. J.; Furth, M. E.; Soker, S.; Atala, A. Isolation of amniotic stem cell lines with potential for therapy. Nat. Biotechnol. 25:100-106; 2007.
13. D'Ippolito, G.; Diabira, S.; Howard, G. A.; Menei, P.; Roos, B. A.; Schiller, P. C. Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential. J. Cell Sci. 117:2971-2981; 2004.
14. Dominici, M.; Le Blanc, K.; Mueller, I.; Slaper-Corten bach, I.; Marini, F.; Krause, D.; Deans, R.; Keating, A.; Prockop, D.; Horwitz, E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317; 2006.
15. Fan, C. G.; Tang, F. W.; Zhang, Q. J.; Lu, S. H.; Liu, H. Y.; Zhao, Z. M.; Liu, B.; Han, Z. B.; Han, Z. C. Characterization and neural differentiation of fetal lung mesenchymal stem cells. Cell Transplant. 14:311-321; 2005.
16. Ferrero, I.; Mazzini, L.; Rustichelli, D.; Gunetti, M.; Mareschi, K.; Testa, L.; Nasuelli, N.; Oggioni, G. D.; Fagioli, F. Bone marrow mesenchymal stem cells from healthy donors and sporadic amyotrophic lateral sclerosis patients. Cell Transplant. 17:255-266; 2008.
17. Fox, J. M.; Chamberlain, G.; Ashton, B. A.; Middleton, J. Recent advances into the understanding of mesenchymal stem cell trafficking. Br. J. Haematol. 137:491-502; 2007.
18. Gang, E. J.; Bosnakovski, D.; Figueiredo, C. A.; Visser, J. W.; Perlingeiro, R. C. SSEA-4 identifies mesenchymal stem cells from bone marrow. Blood 109:1743-1751; 2007.
19. Gonzalez, R.; Maki, C. B.; Pacchiarotti, J.; Csontos, S.; Pham, J. K.; Slepko, N.; Patel, A.; Silva, F. Pluripotent marker expression and differentiation of human second trimester mesenchymal stem cells. Biochem. Biophys. Res. Commun. 362:491-497; 2007.
20. Goshima, J.; Goldberg, V. M.; Caplan, A. I. The osteogenic potential of culture-expanded rat marrow mesenchymal cells assayed in vivo in calcium phosphate ceramic blocks. Clin. Orthop. Relat. Res. 262:298-311; 1991.
21. Gronthos, S.; Brahim, J.; Li, W.; Fisher, L. W.; Cherman, N.; Boyde, A.; DenBesten, P.; Robey, P. G.; Shi, S. Stem cell properties of human dental pulp stem cells. J. Dent. Res. 81:531-535; 2002.
22. Guillot, P. V.; Gotherstrom, C.; Chan, J.; Kurata, H.; Fisk, N. M. Human first-trimester fetal MSC express pluripotency markers and grow faster and have longer telomeres than adult MSC. Stem Cells 25:646-654; 2007.
23. Guo, H.; Fang, B.; Liao, L.; Zhao, Z.; Liu, J.; Chen, H.; Hsu, S. H.; Cui, Q.; Zhao, R. C. Hemangioblastic characteristics of fetal bone marrow-derived Flk1(+)CD31(-) CD34(-) cells. Exp. Hematol. 31:650-658; 2003.
24. Ho, A. D.; Wagner, W.; Franke, W. Heterogeneity of mesenchymal stromal cell preparations. Cytotherapy 10:320-330; 2008.
25. in't Anker, P. S.; Noor, W. A.; Scherjon, S. A.; Kleijburgvan der Keur, C.; Kruisselbrink, A. B.; van Bezooijen, R. L.; Beekhuizen, W.; Willemze, R.; Kanhai, H. H.; Fibbe, W. E. Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential. Haematologica 88:845-852; 2003.
26. Jethva, R.; Otsuru, S.; Dominici, M.; Horwitz, E. M. Cell therapy for disorders of bone. Cytotherapy 11:3-17; 2009.
27. Jiang, Y.; Jahagirdar, B. N.; Reinhardt, R. L.; Schwartz, R. E.; Keene, C. D.; Ortiz-Gonzalez, X. R.; Reyes, M.; Lenvik, T.; Lund, T.; Blackstad, M.; Du, J.; Aldrich, S.; Lisberg, A.; Low, W. C.; Largaespada, D. A.; Verfaillie, C. M. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418:41-49; 2002.
28. Kishi, Y.; Tanaka, Y.; Shibata, H.; Nakamura, S.; Takeuchi, K.; Masuda, S.; Ikeda, T.; Muramatsu, S.; Hanazono, Y. Variation in the incidence of teratomas after the transplantation of nonhuman primate ES cells into immunodeficient mice. Cell Transplant. 17:1095-1102; 2008.
29. Kögler, G.; Sensken, S.; Airey, J. A.; Trapp, T.; Müschen, M.; Feldhahn, N.; Liedtke, S.; Sorg, R. V.; Fischer, J.; Rosenbaum, C.; Greschat, S.; Knipper, A.; Bender, J.; Degistirici, O.; Gao, J.; Caplan, A. I.; Colletti, E. J.; Almeida-Porada, G.; Müller, H. W.; Zanjani, E.; Wernet, P. A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J. Exp. Med. 200:123-135; 2004.
30. Le Blanc, K. Immunomodulatory effects of fetal and adult mesenchymal stem cells. Cytotherapy 5:485-489; 2003.
31. Lee, J. K.; Lee, M. K.; Jin, H. J.; Kim, D. S.; Yang, Y. S.; Oh, W.; Yang, S. E.; Park, T. S.; Lee, S. Y.; Kim, B. S.; Jeun, S. S. Efficient intracytoplasmic labeling of human umbilical cord blood mesenchymal stromal cells with ferumoxides. Cell Transplant. 16:849-857; 2007.
32. Martinez, C.; Hofmann, T. J.; Marino, R.; Dominici, M.; Horwitz, E. M. Human bone marrow mesenchymal stromal cells express the neural ganglioside GD2: A novel surface marker for the identification of MSCs. Blood 109:4245-4248; 2007.
33. Mitchell, K. E.; Weiss, M. L.; Mitchell, B. M.; Martin, P.; Davis, D.; Morales, L.; Helwig, B.; Beerenstrauch, M.; Abou-Easa, K.; Hildreth, T.; Troyer, D.; Medicetty, S. Matrix cells from Wharton's jelly form neurons and glia. Stem Cells 21:50-60; 2003.
34. Nauta, A. J.; Fibbe, W. E. Immunomodulatory properties of mesenchymal stromal cells. Blood 110:3499-3506; 2007.
35. Neuss, S.; Stainforth, R.; Salber, J.; Schenck, P.; Bovi, M.; Knüchel, R.; Perez-Bouza, A. Long-term survival and bipotent terminal differentiation of human mesenchymal stem cells (hMSC) in combination with a commercially available three-dimensional collagen scaffold. Cell Transplant. 17:977-986; 2008.
36. O'Donoghue, K.; Fisk, N. M. Fetal stem cells. Best Pract. Res. Clin. Obstet. Gynaecol. 18:853-875; 2004.
37. Peng, L.; Jia, Z.; Yin, X.; Zhang, X.; Liu, Y.; Chen, P.; Ma, K.; Zhou, C. Comparative analysis of mesenchymal stem cells from bone marrow, cartilage and adipose tissue. Stem Cells Dev. 17:761-773; 2008.
38. Prusa, A. R.; Marton, E.; Rosner, M.; Bernaschek, G.; Hengstschläger, M. Oct-4-expressing cells in human amniotic fluid: A new source for stem cell research? Hum. Reprod. 18:1489-1493; 2003.
39. Ramos, G. A.; Hare, J. M. Cardiac cell-based therapy: Cell types and mechanisms of actions. Cell Transplant. 16:951-961; 2007.
40. Reyes, M.; Lund, T.; Lenvik, T.; Aguiar, D.; Koodie, L.; Verfaillie, C. M. Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 98:2615-2625; 2001.
41. Roobrouck, V. D.; Ulloa-Montoya, F.; Verfaillie, C. M. Self-renewal and differentiation capacity of young and aged stem cells. Exp. Cell Res. 314:1937-1944; 2008.
42. Takahashi, K.; Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676; 2006.
43. Tateishi, K.; Ando, W.; Higuchi, C.; Hart, D. A.; Hashimoto, J.; Nakata, K.; Yoshikawa, H.; Nakamura, N. Comparison of human serum with fetal bovine serum for expansion and differentiation of human synovial MSC: Potential feasibility for clinical applications. Cell Transplant. 17:549-557; 2008.
44. Torrente, Y.; Polli, E. Mesenchymal stem cell transplantation for neurodegenerative diseases. Cell Transplant. 17:1103-1113; 2008.
45. Valtieri, M.; Sorrentino, A. The mesenchymal stromal cell contribution to homeostasis. J. Cell. Physiol. 217:296-300; 2008.
46. Wagner, W.; Wein, F.; Seckinger, A.; Frankhauser, M.; Wirkner, U.; Krause, U.; Blake, J.; Schwager, C.; Eckstein, V.; Ansorge, W.; Ho, A. D. Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp. Hematol. 33:1402-1416; 2005.
47. Wang, X. Y.; Lan, Y.; He, W. Y.; Zhang, L.; Yao, H. Y.; Hou, C. M.; Tong, Y.; Liu, Y. L.; Yang, G.; Liu, X. D.; Yang, X.; Liu, B.; Mao, N. Identification of mesenchymal stem cells in aorta-gonad-mesonephros and yolk sac of human embryos. Blood 111:2436-2443; 2008.
48. Yen, B. L.; Huang, H. I.; Chien, C. C.; Jui, H. Y.; Ko, B. S.; Yao, M.; Shun, C. T.; Yen, M. L.; Lee, M. C.; Chen, Y. C. Isolation of multipotent cells from human term placenta. Stem Cells 23:3-9; 2005.
49. Yen, M. L.; Chien, C. C.; Chiu, I. M.; Huang, H. I.; Chen, Y. C.; Hu, H. I.; Yen, B. L. Multilineage differentiation and characterization of the human fetal osteoblastic 1.19 cell line: A possible in vitro model of human mesenchymal progenitors. Stem Cells 25:125-131; 2007.